Oral anticoagulation for acute coronary syndromes

被引：28

作者：

Brouwer, MA ^{[1
]}

Verheugt, FWA ^{[1
]}

机构：

[1] Univ Nijmegen, Med Ctr, Dept Cardiol 540, Ctr Heart, NL-6500 HB Nijmegen, Netherlands

来源：

CIRCULATION | 2002年 / 105卷 / 11期

关键词：

anticoagulants; aspirin; myocardial infarction;

D O I：

10.1161/hc1102.105594

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1270 / 1274

页数：5

共 30 条

[1] COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS [J].

ALTMAN, R ;

CARRERAS, L ;

DIAZ, R ;

FIGUEROA, E ;

PAOLASSO, E ;

PARODI, JC ;

CADE, JF ;

DONNAN, G ;

EADIE, MJ ;

GAVAGHAN, TP ;

OSULLIVAN, EF ;

PARKIN, D ;

RENNY, JTG ;

SILAGY, C ;

VINAZZER, H ;

ZEKERT, F ;

ADRIAENSEN, H ;

BERTRANDHARDY, JM ;

BRAN, M ;

DAVID, JL ;

DRICOT, J ;

LAVENNEPARDONGE, E ;

LIMET, R ;

LOWENTHAL, A ;

MORIAU, M ;

SCHAPIRA, S ;

SMETS, P ;

SYMOENS, J ;

VERHAEGHE, R ;

VERSTRAETE, M ;

ATALLAH, A ;

BARNETT, H ;

BATISTA, R ;

BLAKELY, J ;

CAIRNS, JA ;

COTE, R ;

CROUCH, J ;

EVANS, G ;

FINDLAY, JM ;

GENT, M ;

LANGLOIS, Y ;

LECLERC, J ;

NORRIS, J ;

PINEO, GF ;

POWERS, PJ ;

ROBERTS, R ;

SCHWARTZ, L ;

SICURELLA, J ;

TAYLOR, W ;

THEROUX, P .

BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921) :81-100

[2] Oral anticoagulant therapy in patients with coronary artery disease: A meta-analysis [J].

Anand, SS ;

Yusuf, S .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (21) :2058-2067

[3]

[Anonymous], 1994, Lancet, V343, P499

[4] Managing oral anticoagulant therapy [J].

Ansell, J ;

Hirsh, J ;

Dalen, J ;

Bussey, H ;

Anderson, D ;

Poller, L ;

Jacobson, A ;

Deykin, D ;

Matchar, D .

CHEST, 2001, 119 (01) :22S-38S

[5]

ARNESEN H, 2001, 23 EUR C CARD SEPT 1

[6] TRIAL OF COMBINED WARFARIN PLUS DIPYRIDAMOLE OR ASPIRIN THERAPY IN PROSTHETIC HEART-VALVE REPLACEMENT - DANGER OF ASPIRIN COMPARED WITH DIPYRIDAMOLE [J].

CHESEBRO, JH ;

FUSTER, V ;

ELVEBACK, LR ;

MCGOON, DC ;

PLUTH, JR ;

PUGA, FJ ;

WALLACE, RB ;

DANIELSON, GK ;

ORSZULAK, TA ;

PIEHLER, JM ;

SCHAFF, HV .

AMERICAN JOURNAL OF CARDIOLOGY, 1983, 51 (09) :1537-1541

[7] Drug therapy: Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction [J].

Collins, R ;

Peto, R ;

Baigent, C ;

Sleight, P .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (12) :847-860

[8] A synthetic factor-Xa inhibitor (ORG31540/SR9017A) as an adjunct to fibrinolysis in acute myocardial infarction - The PENTALYSE study [J].

Coussement, PK ;

Bassand, JP ;

Convens, C ;

Vrolix, M ;

Boland, J ;

Grollier, G ;

Michels, R ;

Vahanian, A ;

Vanderheyden, M ;

Rupprecht, HJ ;

Van de Werf, F .

EUROPEAN HEART JOURNAL, 2001, 22 (18) :1716-1724

[9] Oral anticoagulation self-management and management by a specialist anticoagulation clinic:: a randomised cross-over comparison [J].

Cromheecke, ME ;

Levi, M ;

Colly, LP ;

de Mol, BJM ;

Prins, MH ;

Hutten, BA ;

Mak, R ;

Keyzers, KCJ ;

Büller, HR .

LANCET, 2000, 356 (9224) :97-102

[10] Department of Veterans Affairs Cooperative Studies Program clinical trial comparing combined warfarin and aspirin with aspirin alone in survivors of acute myocardial infarction - Primary results of the CHAMP study [J].

Fiore, LD ;

Ezekowitz, MD ;

Brophy, MT ;

Lu, D ;

Sacco, J ;

Peduzzi, P .

CIRCULATION, 2002, 105 (05) :557-563

← 1 2 3 →